🇪🇺 Fast delivery (3–5 working days) with GLS ✅ Card or bank transfer 📦 Free shipping from €50

Hexarelin
Peptology Ltd. · Recovery and anabolic peptides
Hexarelin 5 mg – a synthetic hexapeptide of the GHRP group, a ghrelin receptor (GHS-R1a) agonist and a structural analogue of GHRP-6; a research peptide, also studied together with GHRH analogues (such as CJC-1295). Purity 99%+, HPLC/MS report for every batch.
📦 The product is in our EU warehouse – delivery within 3–5 working days.
28,00 € · In stock
For research use only / Not a medicine



| Purity | >99% |
|---|---|
| Method | HPLC + LC/MS |
| Laboratory | Analiza Białek |
| Batch | 0226 |
Hexarelin is a synthetic hexapeptide of the GHRP group (growth-hormone-releasing peptides) and a ghrelin receptor agonist (GHS-R1a). It is a structural analog of GHRP-6, but with greater stability and higher receptor affinity — in the literature described as the most potent synthetic GH secretagogue, triggering the release of growth hormone at doses up to 10 times lower than GHRP-6.
Two features distinguish Hexarelin. First — potency: it binds GHS-R1a more strongly than ghrelin itself and produces the strongest GH pulses among the classic GHRPs, additionally inhibiting somatostatin (the hormone that blocks GH). Second — cardioprotective action via the CD36 receptor, which in studies is described as independent of growth hormone (observed even in GH-deficient models). This distinguishes Hexarelin from the other secretagogues.
Hexarelin acts on the GHS-R1a receptor — the same one as Ipamorelin or GHRP-2, but distinct from the GHRH receptor targeted by analogs like CJC-1295. Because these are two independent pathways, combining Hexarelin with a GHRH analog gives a strong synergistic effect in studies.
Hexarelin is studied in the context of the GH/IGF-1 axis, hypertrophy, regeneration and cardiovascular function. It is a research peptide — it holds no authorization as a medicinal product. It belongs to the category recovery and anabolic peptides.
In the version offered by Peptology, Hexarelin is supplied as a lyophilized peptide with purity above 99% (HPLC/MS), confirmed by independent laboratory analysis (CoA for every batch), in a 5 mg vial size. The product is intended exclusively for scientific research and in vitro applications.
Hexarelin is available in a 5 mg lyophilized format that covers typical research scales — from single in vitro series to longer GH-axis protocols, including schedules combined with a GHRH analog.
5 MG
Standard vial size
Lyophilized GHRP hexapeptide with purity > 99%, for research on the GH axis, hypertrophy and cardiovascular function.
COMBINED SCHEDULE
Classic research model: Hexarelin (GHRP) + CJC-1295 (GHRH) — two receptors, synergistic effect.
The 5 mg vial size has purity > 99% and a laboratory certificate for the batch. Due to Hexarelin's high potency, precise dose calculation is important.
In the research literature, Hexarelin is described as a molecule with three characteristic features — exceptional potency, cardiac action and a tendency toward receptor desensitization. These three elements together define its profile.
GHS-R1a RECEPTOR
Binds the ghrelin receptor more strongly than ghrelin itself and inhibits somatostatin — producing the strongest GH pulses among the classic GHRPs.
CD36 RECEPTOR (HEART)
Activates the CD36 receptor in cardiac tissue — in studies associated with GH-independent cardioprotection (protection from ischemia, better calcium handling).
DESENSITIZATION
High affinity means faster receptor desensitization — which is why protocols use short cycles with breaks.
Hexarelin is the most potent of the classic GHRPs — it produces larger GH pulses than GHRP-2 or GHRP-6 at the same molar dose. Additionally, its action via the CD36 receptor makes it unique in this class: in research models its cardioprotective effect was observed even under GH deficiency, indicating a mechanism independent of the growth axis.
The flip side of high potency is faster desensitization of the GHS-R1a receptor, which is why Hexarelin is used in shorter cycles than other GHRPs. In research schedules it is combined with a GHRH analog (e.g. CJC-1295) acting on a separate receptor. This data comes from pharmacological studies and does not constitute a claim about the effect of the research-grade product.
Hexarelin is a metabolically stable hexapeptide, described in the published data as a fast-acting secretagogue with a short profile, triggering a strong GH pulse soon after administration.
The table below compares three GHRP secretagogues acting on the same GHS-R1a receptor, but differing in potency, selectivity and side-effect profile. Hexarelin is the most potent, Ipamorelin the cleanest, and GHRP-6 stands out for strong appetite stimulation. The data are scientific and comparative in nature.
| Hexarelin | Ipamorelin | GHRP-6 | |
|---|---|---|---|
| GH pulse strength | Extremely high (the strongest) | Moderate to high | High |
| Effect on appetite | Minimal / none | None | Very strong (intense hunger) |
| Effect on cortisol / prolactin | Minimal (possible at high doses) | Minimal to none (the cleanest) | Moderate increase |
| Desensitization risk | High (short cycles) | Low | Moderate |
| Distinguishing feature | Potency + cardioprotection (CD36) | Clean GH profile | Appetite stimulation |
The values are approximate and come from the pharmacological literature on GH secretagogues. The table is scientific and comparative in nature and does not constitute a direct head-to-head comparison or a claim about the effect of the research-grade product.
Hexarelin is one of the best-studied GH secretagogues and an object of particular interest because of its cardiac action. Below are the most important observations from the literature.
In studies, Hexarelin produced a marked increase in plasma GH concentrations soon after administration — stronger than other classic GHRPs at an equivalent dose. This profile makes it a tool for research on peak GH pulses and the GH/IGF-1 axis.
A distinguishing feature of Hexarelin is its cardioprotective action, associated with the CD36 receptor and the regulation of calcium handling in cardiomyocytes, as well as protection from ischemia-reperfusion injury. In research models these effects were observed even under GH deficiency, indicating a mechanism independent of the growth axis.
The combination of Hexarelin with a GHRH analog (like CJC-1295) is in studies associated with stronger GH release than either component alone. At the same time, high receptor affinity leads to faster desensitization, which is why the literature recommends shorter cycles with breaks.
Note: The information is presented for scientific and informational purposes and is based on the pharmacological and preclinical literature. It does not constitute medical advice, a recommendation for use or a claim about the effect of the research-grade product offered by Peptology.
All information provided refers to the pharmacological and preclinical literature on Hexarelin and should not be interpreted as a promise of effect, an instruction for use or a claim about the effect of the research-grade product offered by Peptology.
Important: The information below describes schedules used in research on Hexarelin. It is provided for scientific and informational purposes and does not constitute a recommendation for individual use, medical advice or administration instructions. The research-grade Hexarelin offered by Peptology is not a registered drug.
Due to its high potency and tendency toward desensitization, Hexarelin is used in studies in short cycles, subcutaneously:
In GH-axis protocols, Hexarelin is sometimes combined with CJC-1295, and in regenerative protocols with BPC-157. These schedules come from the research literature and do not constitute a recommendation for self-administration.
In research observations, Hexarelin is described as well tolerated with correctly planned cycles. Side effects are usually mild and dose-dependent, and the key aspect specific to this molecule is receptor desensitization.
Frequently observed (mild)
At high doses
Specific to Hexarelin
Most side effects are mild and reversible, and desensitization is limited through cyclicity. This information is scientific in nature and does not constitute an instruction for use.
Hexarelin is supplied as a lyophilized (freeze-dried) powder in a vial. In lyophilized form it is stable at room temperature, protected from light and moisture — refrigeration before reconstitution is not mandatory. After reconstitution, stability depends on the solvent used, with Peptide Matrix Water™ significantly extending the peptide's lifespan.
Laboratory tip: With your order, you can add Peptide Matrix Water™ to the cart — a stabilizing solution designed for working with reconstituted research peptides. More in the article Bacteriostatic water vs acetic acid vs matrix water.
It is a synthetic hexapeptide of the GHRP group and a ghrelin receptor agonist (GHS-R1a), described as the most potent growth hormone secretagogue. It stands out for its additional cardioprotective action via the CD36 receptor. The results come from the pharmacological and preclinical literature.
Peak plasma GH concentrations are usually reached about 30 minutes after administration, which makes it one of the fastest-acting secretagogues.
Hexarelin is the most potent of the three and the only one to show cardioprotective action via CD36. Ipamorelin is the cleanest (minimal effect on other hormones), and GHRP-6 strongly stimulates appetite. Hexarelin also requires shorter cycles due to desensitization.
Yes — it is classically combined with a GHRH analog, like CJC-1295 (two separate receptors, synergy), and in regenerative protocols with BPC-157.
The lyophilized vial is stored at room temperature, protected from light and moisture. After reconstitution, stability depends on the solvent: with Peptide Matrix Water™ — up to 60 days in the refrigerator +2 °C to +8 °C; with bacteriostatic or sterile water — up to 28 days. Avoid refreezing.
Peptology offers Hexarelin 5 mg as a research peptide with confirmed purity above 99% (HPLC/MS) and independent laboratory analysis for every batch. Fast shipping, discreet packaging and certificates of purity with the product. For scientific background, also see the article Peptides — what they are, how they work, main categories and safety profile.
Researchers working with Hexarelin often also consider other GHRP secretagogues, GHRH analogs and regenerative peptides. Each of the products below has a certificate of purity above 99%:
Ipamorelin
The cleanest, selective GH secretagogue
GHRP-6
GH secretagogue that strongly stimulates appetite
GHRP-2
Strong ghrelin mimetic (GHS-R1a)
CJC-1295 without DAC
GHRH analog — a partner for synergy
BPC-157
Regenerative peptide
Peptide Matrix Water™
Stabilizing solution for reconstitution
See the full catalog: Recovery and anabolic peptides · Solutions for peptides · All peptides · Blog on peptide research
Research warning: Hexarelin is offered exclusively for scientific research and in vitro purposes. It is not a medicinal product, is not approved for use in humans or animals, and does not replace medical advice. All information comes from the pharmacological and preclinical literature and is provided for scientific and informational purposes; it does not constitute a claim about the effect of the research-grade product offered by Peptology.
Standardized protocol applicable to all research peptides in the Peptology catalogue. To calculate the solution concentration (mg/mL) for each vial, use the peptide reconstitution calculator.
1. SOLVENT
2. RECONSTITUTION
Add the solvent down the side of the vial, without shaking, wait 10–15 min.
3. CALCULATION
Calculator → concentration mg/mL
4. STORAGE
+2 °C to +8 °C, up to 60 days with Peptide Matrix Water
| Parameter | Value |
|---|---|
| Form | Lyophilized powder |
| Solvent | Peptide Matrix Water |
| Reconstitution volume | 1–3 mL — maximum 3 mL (capacity of the standard vial) |
| Storage before reconstitution | Room temperature, protected from direct light (refrigeration not required) |
| After reconstitution | Up to 60 days at +2 °C to +8 °C with Peptide Matrix Water |
Precision pipette
Calibrated, 100–1000 µL — for accurately measuring the volume of solvent added to the vial.
70% alcohol swabs
Two swabs — to disinfect the peptide vial and the solvent vial.
Stabilized solvent for lyophilized peptides. Why this one.
| ✅ Correct | ❌ Mistake |
|---|---|
| Disinfect the vial caps and the work surface with 70% alcohol; wear gloves | Working without disinfection |
| Add the solvent slowly along the vial wall | Direct jet onto the powder — foaming and denaturation |
| Gentle rolling between the palms | Shaking — foam, which denatures peptides |
| 10–15 minutes waiting at room temperature | Mechanical mixing or heating |
| Visual check: clear, particle-free | Working with a cloudy or discolored solution |
⚠️ Maximum 3 mL solvent. The standard vial does not accommodate larger volumes — do not exceed during reconstitution.
Reconstitution per vial — solvent: Peptide Matrix Water. Concentration after adding the solvent (1 mg/mL = 1 µg/µL):
| Vial | + 1 mL | + 2 mL | + 3 mL |
|---|---|---|---|
| 5 mg | 5 mg/mL | 2.5 mg/mL | 1.67 mg/mL |
👉 For any vial and solvent volume — use the calculator. It calculates the concentration (mg/mL, µg/µL) and the volume per sample (mL, µL).
BEFORE RECONSTITUTION
Room temperature, protected from direct light, in original packaging. Refrigerator not required.
AFTER RECONSTITUTION
+2 °C to +8 °C, up to 60 days with Peptide Matrix Water. Discard any remainder after this period.
FREEZING
Not recommended. Freeze/thaw cycles degrade peptide structure.
1. Shaking "to dissolve faster"
Foam = denaturation. Only gentle rolling between the palms.
2. Inappropriate solvent
For peptide stability use only sterile, specially formulated solvent — recommended Peptide Matrix Water.
3. Ignoring slight turbidity
Not fully clear = the sample does not meet the criteria for use.
4. Taking it out of the refrigerator "for an hour–two"
Short exposures add up and compromise stability.
Research status: All Peptology products are intended for laboratory and research use only. They are not medicinal products, not approved for human or veterinary use and do not substitute medical advice. The described protocol is standard laboratory practice for working with lyophilized peptides.
Products in our warehouse – orders placed by 15:00 on working days are dispatched the same day, later orders on the next working day.
Delivery with GLS to your address in 3–5 working days.
Shipping costs €5 and is free from €50.
As a lyophilised powder in a sealed 5 mg vial. Before reconstitution store it at room temperature, protected from light and moisture; after reconstitution keep it at +2 to +8 °C (up to 60 days with Peptide Matrix Water).
Purity above 99%, confirmed by HPLC and mass spectrometry for every batch. The certificate of the current batch is shown in the “Laboratory Analysis” tab.
No – the product is intended for research and laboratory use only.
You can buy Hexarelin in Europe online from Peptology, from 28,00 €. Delivery with GLS in 3–5 working days. Shipping is free from 50,00 €. Payment by card. Purity 99%+, with an HPLC report for every batch.
